Seeking Alpha

Thoratec (THOR) shares look to benefit after new data says that patients implanted with a...

Thoratec (THOR) shares look to benefit after new data says that patients implanted with a mechanical heart assistance device by rival HeartWare (HTWR) have an unexpectedly high 9.2% chance of developing a potentially life-threatening blood clot per year. THOR +14.5%, HTWR -16.5% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)